(a) Notice of intermediate sanction and opportunity to respond—
(1) Notice of intent.
Before imposing the intermediate sanctions, CMS—
(i)
Sends a written notice to the Part D plan sponsor stating the nature and basis of the proposed intermediate sanction, and the Part D plan sponsor's right to a hearing as specified in paragraph (b) of this section; and
(ii)
Sends the OIG a copy of the notice.
(2) Opportunity to respond.
CMS allows the Part D plan sponsor 10 calendar days from receipt of the notice to provide a written rebuttal. CMS considers receipt of notice as the day after notice is sent by fax, e-mail, or submitted for overnight mail.
(b) Hearing.
(1)
The Part D plan sponsor may request a hearing before a CMS hearing officer.
(2)
A written request must be received by the designated CMS office within 15 calendar days after the receipt of the notice.
(3)
A request for a hearing under § 423.650 of this part does not delay the date specified by CMS when the sanction becomes effective.
(4)
The Part D plan sponsor must follow the right to a hearing procedure as specified at § 423.650 through § 423.662 of this part.
(c) Effective date and duration of sanctions.
(1) Effective date.
The effective date of the sanction is the date specified by CMS in the notice.
(2) Exception.
If CMS determines that the Part D sponsor's conduct poses a serious threat to an enrollee's health and safety, CMS may make the sanction effective on an earlier date that CMS specifies.
(3) Duration of sanction.
The sanction remains in effect until CMS is satisfied that the deficiencies that are the basis for the sanction determination have been corrected and are not likely to recur.
(i)
CMS may require that the Part D plan sponsor hire an independent auditor to provide CMS with additional information to determine if the deficiencies that are the basis for the sanction determination have been corrected and are not likely to recur. The independent auditor must work in accordance with CMS specifications and must be willing to attest that a complete and full independent review has been performed.
(ii)
In instances where marketing or enrollment or both intermediate sanctions have been imposed, CMS may require a Part D plan sponsor to market or to accept enrollments or both for a limited period of time in order to assist CMS in making a determination as to whether the deficiencies that are the bases for the intermediate sanctions have been corrected and are not likely to recur.
(A)
If, following this time period, CMS determines the deficiencies have not been corrected or are likely to recur, the intermediate sanctions will remain in effect until such time that CMS is assured the deficiencies have been corrected and are not likely to recur.
(B)
The Part D plan sponsor does not have a right to a hearing under § 423.650(a)(4) of this subpart to challenge CMS' determination to keep the intermediate sanctions in effect.
(d) Termination by CMS.
In addition to or as an alternative to the sanctions described in paragraph (c) of this section, CMS may decline to authorize the renewal of an organization's contract in accordance with § 423.507(b)(2) and (b)(3), or terminate the contract in accordance with § 423.509.
(e) Notice to impose civil money penalties—
(1) CMS notice to OIG.
If CMS determines that a Part D sponsor has committed an act or failed to comply with a requirement as described in 423.752, CMS notifies the OIG of this determination. OIG may impose a civil money penalty upon a Part D sponsor as specified at 423.752(c)(2).
(2) CMS notice of civil money penalties to Part D plan sponsors.
If CMS makes a determination to impose a CMP described in 423.752(c)(1), CMS will send a written notice of the Agency's decision to impose a civil money penalty to include—
(i)
A description of the basis for the determination.
(ii)
The basis for the penalty.
(iii)
The amount of the penalty.
(iv)
The date the penalty is due.
(v)
The Part D sponsor's right to a hearing as specified under Subpart T of this part.
(vi)
Information about where to file the request for hearing.
[70 FR 4525, Jan. 28, 2005, as amended at 72 FR 68735, Dec. 5, 2007; 73 FR 55764, Sept. 26, 2008; 75 FR 19825, Apr. 15, 2010]